Patents Assigned to EpiCypher, Inc.
  • Patent number: 11739128
    Abstract: The invention relates generally to methods for preparing recombinant nucleosomes. In particular, the invention relates to methods for ligating a histone peptide onto a fully assembled recombinant nucleosome. The invention further relates to modified core histone proteins, histone peptides to be ligated to the modified core histone proteins, and fully assembled recombinant nucleosomes and libraries of recombinant nucleosomes prepared by the methods of the invention.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: August 29, 2023
    Assignee: EPICYPHER, INC.
    Inventors: Martis William Cowles, Michael-Christopher Keogh, Jonathan M. Burg, Zu-Wen Sun
  • Patent number: 11493520
    Abstract: The invention relates to assays for nucleosome remodeling activity using functionalized recombinant mononucleosomes. The functionalized recombinant mononucleosomes comprise a histone octamer comprising recombinant histone H2A, H2B, H3 and H4 proteins and a DNA template comprising a nucleosome positioning sequence that effectively positions the histone octamer and a signal site. The invention further relates to methods of using the assay to quantify enzymatic activity of remodeling enzymes and identifying modulators of remodeling enzyme activity.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: November 8, 2022
    Assignee: EpiCypher, Inc.
    Inventors: Michael-Christopher Keogh, Martis William Cowles, Matthew Fruge Whelihan
  • Patent number: 10787697
    Abstract: The invention relates to the use of recombinant/semi-synthetic nucleosomes carrying histone and/or DNA modifications as a reference standard for quantification of covalently modified (on the histone proteins or wrapping DNA), variant, or mutant nucleosomes (collectively “modified nucleosomes” or “nucleosome modifications”) from a biological sample. The invention further relates to methods of using the assay to accurately quantify single or combinatorial nucleosome modifications as biomarkers of disease.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: September 29, 2020
    Assignee: EpiCypher, Inc.
    Inventors: Martis William Cowles, Matthew F. Whelihan, Andrea L. Johnstone, Michael-Christopher Koegh, Zu-Wen Sun, Nathan W. Hall, Matthew R. Marunde